
Germany · Biotechnology startup
AiCuris is a pharmaceutical company that discovers, researches and develops antiviral and antibacterial agents to treat infectious diseases.
Funding reportedLast round: Series B
Funding, as reported
From AiCuris's own website: 2 founders, 20 on the team.
And 2 more on the team.
Add your raise, your deck and your story, and put AiCuris in front of investors. Or tell us what we have wrong.